{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-031982","form_type":"8-K","ticker":"BCTX","cik":"0001610820","company_name":"BriaCell Therapeutics Corp.","filed_at":"2023-09-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.547688+00:00","generated_at":"2026-06-10T22:51:23.035531+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"BriaCell Therapeutics amends articles after share exchange under arrangement","bullets":["Amended notice of articles and articles effective August 31, 2023.","All existing BriaCell common shares exchanged for new shares with identical rights.","Outstanding share count remains 15,981,726 following the exchange.","Shareholders retain one vote per share and dividend/liquidation rights unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-031982","json":"https://secwatch.observer/filing/0001493152-23-031982.json","markdown":"https://secwatch.observer/filing/0001493152-23-031982.md","text":"https://secwatch.observer/filing/0001493152-23-031982.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610820/000149315223031982/0001493152-23-031982-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610820/000149315223031982/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T22:51:23.035531+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bd6943ba308eac612fecfa8ffaad635844cafb37","claim":"BriaCell Therapeutics Corp.: Amended notice of articles and articles to effect share exchange pursuant to arrangement agreement (effective 2023-08-31).","evidence_excerpt":"On August 31, 2023, 2023, BriaCell Therapeutics Corp. (the “Company”) amended its articles pursuant to the previously disclosed arrangement agreement (the “Agreement”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1610820/000149315223031982/0001493152-23-031982-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-08-31"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}